Healthy tissues surrounding abdomino-pelvic tumours can be impaired by radiotherapy, leading to chronic gastrointestinal complications with substantial mortality. Adipose-derived Mesenchymal Stromal Cells (Ad-MSCs) represent a promising strategy to reduce intestinal lesions. However, systemic administration of Ad-MSCs results in low cell engraftment within the injured tissue. Biomaterials, able to encapsulate and withstand Ad-MSCs, can overcome these limitations. A silanized hydroxypropylmethyl cellulose (Si-HPMC) hydrogel has been designed and characterized for injectable cell delivery using the operative catheter of a colonoscope. We demonstrated that hydrogel loaded-Ad-MSCs were viable, able to secrete trophic factors and responsive to the inflammatory environment. In a rat model of radiationinduced severe colonic damage, Ad-MSC þ Si-HPMC improve colonic epithelial structure and hyperpermeability compared with Ad-MSCs injected intravenously or locally. This therapeutic benefit is associated with greater engraftment of Si-HPMC-embedded Ad-MSCs in the irradiated colonic mucosa. Moreover, macrophage infiltration near the injection site was less pronounced when Ad-MSCs were embedded in the hydrogel. Si-HPMC induces modulation of chemoattractant secretion by Ad-MSCs that could contribute to the decrease in macrophage infiltrate. Si-HPMC is suitable for cell delivery by colonoscopy and induces protection of Ad-MSCs in the tissue potentiating their therapeutic effect and could be proposed to patients suffering from colon diseases.
Introduction
Radiotherapy plays a crucial in the management of malignant pelvic diseases. However, the major limitation of this treatment is its toxicity on surrounding healthy tissues such as the small intestine, colon and rectum. Due to the high proliferative capacity of epithelial stem cells located at the base of the crypts, the gut is a very radiosensitive organ. Irradiation produces free radicals that, through direct and indirect effects, induce crypt cell apoptosis leading to mucosal lesions with a loss of epithelial barrier function. The intestinal epithelial barrier is maintained by intracellular junctional complexes, such as tight junctions (TJs), adherent junctions and desmosomes. Irradiation increases mucosal permeability, inducing nutrient and fluid loss as well as gut pathogen infiltration, exacerbating mucosal inflammation [1] . This inflammatory state, combined with the deficiency of epithelial stem cells and local ischemia, leads to a defective healing process which can result in tissue loss (ulceration) or pathological healing (fibrosis, fistula) [2] .
Patients (10e20%) undergoing radiotherapy for abdominal cancers develop intestinal complications several years after the end of their treatment. These chronic complications adversely affect quality of life and, in some cases, can be life-threatening. Management of patients suffering from radiotherapy-related gastrointestinal disorders is limited to symptomatic treatments. No curative treatments are currently available. Therefore, symptoms reoccur once treatment is stopped and new features may arise depending upon the course of the disease. The lack of curative treatment and the potential severity of the gastrointestinal disorders highlight the importance of finding a novel and effective treatment. Stem cellbased regenerative medicine using mesenchymal stromal cells (MSCs) is considered a promising approach, as suggested by encouraging results from various clinical trials [1] .
Convincing experimental results from different animal models [3e5] and in clinical cases treated on a compassionate basis [6, 7] have shown that intravenous (IV) injection of MSCs reduces severe colorectal lesions caused by ionizing irradiation. Experiments performed on animal models have shown that IV-MSC treatment promotes epithelial regeneration leading to intestinal structure improvement and limiting the fibrosis process [3e5]. The beneficial effects of MSC injection have been primarily related to their secretion of a wide variety of bioactive molecules [8] . MSCs secrete angiogenic, pro-regenerative, anti-apoptotic and immunosuppressive factors that may contribute to intestinal ulcer wound healing. Moreover, pre-clinical data on mini-pigs has demonstrated that repeated intravenous MSC injections are necessary to improve radio-induced colorectal ulcer healing [9] . These data suggest that MSC-induced therapeutic benefit requires a large number of injected cells. Despite a large amount of MSCs being systemically injected, very low cell engraftment in the irradiated intestine has been reported [3, 4] . Indeed, studies have demonstrated that systemically injected MSCs were trapped in the lung after infusion [10] . Although a study from Prockop group has demonstrated that the anti-inflammatory effects of MSCs depend upon their trapping in the lung [11] , some studies have demonstrated a pulmonary embolus following intravenous injection of MSCs [12e14] . It is known that MSCs are short-lived when infused intravenously. Indeed, they die within 24 h and are cleared from the body [15] . Thus, local injection of cells has been tested according to the accessibility of the tissue [16] . This injection method allows fewer cells to be injected, increases the rate of MSC engraftment in the area requiring repair and interestingly, for clinical application, reduces the cost of the treatment. Moreover, local injection reduces the spread of stem cells throughout the body, although no side effects have been shown after either local or intravenous injection of MSCs [17, 18] . While local injection leads to better cell engraftment, cell viability could be limited due to the host microenvironment, particularly in the case of radiotherapy. After colorectal irradiation, the secretion of pro-inflammatory cytokines as IL1b, TGFb and chemoattractant has been demonstrated, as well as the huge infiltrate of innate immune cells [19, 20] . In order to overcome these drawbacks, the use of a hydrogel that entraps the MSCs may protect the cells from the host tissue environment. The cytoprotective properties of the hydrogel could maintain the viability and function of the cells. This biomaterial-assisted cell therapy may make it possible to significantly increase the therapeutic benefit with a reduced number of injections. Indeed, in cases of ischemia (heart and hindlimb), studies have demonstrated that injection of MSCs embedded in biomaterials enhances their therapeutic benefit [21, 22] . This method of injection is also used for articular cartilage repair by direct implantation with minimally invasive surgery [23] .
Amongst the wide variety of biomaterials, biocompatible hydrogels may represent an excellent cell delivery system in view of their distinctive property of permitting in-situ gelation. Two types of hydrogels exist: natural and synthetic. Natural hydrogels are used as scaffolds because they display numerous biological functions that synthetic polymers lack, such as cell adhesion and biodegradation. A hybrid semi-synthetic, semi-biological silanized hydroxypropylmethyl cellulose (Si-HPMC) hydrogel has been designed as an injectable cell carrier. This Si-HPMC hydrogel is biocompatible, able to self-crosslink in situ to form a scaffold and maintain MSC phenotype, viability and secretion ability [23] . Indeed, Mathieu et al. have demonstrated the beneficial effect of Si-HPMC hydrogel in cardiac tissue engineering with a pronounced improvement in cardiac capacity after infarction when MSCs were injected within the biomaterial [22] .
Here, we aimed to use a Si-HPMC hydrogel with rheological properties compatible with clinical use through a specific colonoscope catheter. We evaluated the effects of hydrogel-assisted Ad-MSC therapy compared with conventional intravenous injections of MSCs as used in clinical applications on structural and functional damage induced on a rat model of colorectal irradiation [4] . We also followed the engraftment of the Ad-MSCs and their fate in the lesion site. Lastly, we studied the hydrogel's ability to protect the cells from the deleterious irradiated environment.
Materials and methods

Ethics statement
All experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals as published by the French regulations for animal experiments (Ministry of Agriculture Order No. B92-032-01, 2006) with European Directives (86/609/ CEE) and were approved by local ethical committee of the institute (permit number P13-14).
Animals and irradiation protocol
Male SD (Sprague Dawley, non-consanguineous) rats (Janvier SA, Le Genest St Isle, France) weighing 250 g were received and housed in a temperature-controlled room (21 ± 1 C). They were allowed free access to water and fed standard pellets. Rats were anesthetized by isoflurane inhalation and a single 29 Gray (Gy) dose was delivered by a medical accelerator (Alph ee) through a 2 Â 3 cm window centered on the colorectal region. Alph ee is an accelerator-type radiation source (maximal energy is 4 MeV with an average energy of about 1.5 MeV; 30 kA).
Cell culture and characterization
Adipose-derived MSCs were obtained by digesting the subcutaneous inguinal adipose tissue of seven-week-old GFP-transgenic SD rats as previously described [5] . After 7 days, the monolayer of adherent cells was trypsinized, washed in PBS three times before injection in rats. The phenotype of amplified Ad-MSC was verified by flow cytometry. The percentage of CD90 (clone OX-7; BD Biosciences, Le pont de Claix, France) and CD73 (clone 5F/B9; BD Biosciences) positive cells were analyzed and the absence of hematopoietic cells was verified with CD34 (clone ICO115, Santa Cruz, Dallas, Texas, USA) and CD45 (clone OX-1; BD Biosciences) markers. Isotype identical antibodies served as controls. On average, Ad-MSC expressed CD90 at 95.25% (±2.7), CD73 at 65.42% (±18.9), CD34 at 1.45% (±1.01) and CD45 at 0.575% (±0.2). The potential of adipogenic and osteogenic differentiations was also evaluated.
Hydrogel preparation
Hydroxypropyl methyl cellulose (Methocel ® E4M Premium procured from Colorcon) was silanized by grafting 3-glycidoxypropyltrimethoxysilane GPTMS as previously described [24] . Si-HPMC powder was dissolved in NaOH solution (0.2 M) then dialyzed to reach a final pH value of 12.7 [25] . Acidic buffer solution used to neutralize the basic Si-HPMC solution was prepared using 0.1 M HCl and HEPES as previously described [25] . Si-HPMC hydrogels were prepared by rapidly mixing the polymer and the buffer at a ratio of 2:1 leading to a pH of 7.4 and then, initiating silanol condensation.
Injectability of the hydrogel
The injectability was measured using a compression testing device (TAHDplus) with 5 kg load cell utilized for the measurements. Five kg is the maximum force that can be applied by hand. Si-HPMC at either concentrations of 1% and 1.5% were pre-loaded into the catheter. A syringe containing 1 ml 0.1 M NaCl (SigmaAldrich, Germany) was attached to the catheter and the injection force was measured.
2.6. Rheological characteristics 2.6.1. Viscosity
Intrinsic viscosity was measured using a steady shear rate ranging from 0.1 to 100 s À1 at room temperature. The subsequent flow curves were fitted using the simplified Cross equation for each of the Si-HPMC concentrations measured to calculate the limiting viscosity [26] .
Gel point measurements
The gel point was measured on HAAKE RheoStress RS300 rheometer (Thermo Scientific) using cone/plate geometry (1 / 60 mm). Liquid hydrogel precursor solutions were injected on the plate immediately after mixing and the measurements started 1e2 min later. Storage (G') modulus was monitored as a function of time under oscillation frequency sweep (from 1 to 22 Hz) at a constant temperature (23 C). The gel point was determined when tan d ¼ G 00 /G 0 became independent from frequency. Each sample was measured in triplicate.
Elastic modulus measurements
Storage (G 0 ) modulus of fully cross-linked hydrogels was measured using a plate geometry (PP20 Ti) under oscillatory mode with a shear stress ranging from 0.1 to 3000 Pa. Initially, 1% and 1.5% (w/v) Si-HPMC was formulated and poured (2 mL) into 12-well plates. Plates were placed either at room temperature or a 37 C incubator under a humid atmosphere to prevent drying and allowed to set for 14 days. Plate was loaded onto a specially designed plate platform for the rheometery measurement and then a 0.5 N normal force was applied prior to measurement. G 0 for Si-HPMC at each concentration was determined from the graphs.
Ad-MSC viability, morphology and proliferation within the hydrogel
Cells were seeded at 3.33 Â 10 6 cells/ml with each individual gel containing approximately 1 Â 10 6 cells. Cell viability was evaluated using Calcein AM-ethidium homodimer assay (Live and Dead ® , Invitrogen, France) and then observed using a confocal microscope. Images were then assessed using commercial software (Velocity, Nikon corporation) to count the number of green (live) and red (dead) cells from each sample. Samples stained yellow (dual stained red and green) upon analysis were counted as dead cells. Cells were cultured for a 21 day period with live/dead assessment conducted on day 1, 7, 14 and 21 during culture. A set of cells was cultured in the presence of actinomycin D (10 mg/ml) to act as a negative control for the study. Proliferation analyses were realized using immunofluorescence. Cells were loaded on the lab-Tek chamber slide system (Nunc) with or without hydrogel during 72 h in culture medium. After PBS 1X washing, the cells were fixed then permeabilized with TritonX-100 0.5% during 15min and incubated overnight with mouse anti PCNA (M0879, DakoCytomation). Staining was revealed using a fluorescent secondary antibody (1/200eme goat anti-mouse Alexa 488, A11017, Invitrogen). After washing, nuclei were stained with DAPI (Vector Labs).
Experimental protocol
In two series of experiments, 3 weeks after irradiation, rats were injected with either 5. 
Ussing chambers experiments
Immediately after the sacrifice, distal colons were removed, cut along the mesenteric border, and three colonic strips from each rat were mounted in Ussing chambers (Corning Costar Corporation, Harvard Apparatus, France) having a flux area of 0.1 cm 2 . Colonic epithelial permeability to small and large molecules was measured through the mucosal-to-serosal passage of fluoro isothiocyanate (FITC)-Dextran 4 kDa (FD4) and intact Horseradish peroxidase (HRP) 44 kDa (Sigma-Aldrich, Saint Quentin Fallavier, France), respectively, added simultaneously in the mucosal compartment.
After 20 min of equilibration, 600 ml of buffer solution on the mucosal side was replaced by 300 ml of FD4 (2.2 mg/ml, SigmaAldrich) and 300 ml of HRP (0.4 mg/ml, Sigma-Aldrich). Electrical parameters, including potential difference, short-circuit current (Isc) and total electrical resistance (R), were recorded at regular intervals during the 2-h period of experimentation. Colonic permeability to FD4 was determined by measuring the fluorescence intensity at 485 nm/525 nm using an automatic Infinite M200 microplate reader (Tecan, Lyon, France). Epithelial permeability to intact HRP was determined by an enzymatic assay [27] for specific HRP activity found in the serosal and mucosal compartment using a microplate reader (Tecan). Permeability was calculated as the ratio of flux/concentration, as previously described [28] and expressed in cm/second.
Tissue protein extraction and claudin 4 expression by western blot
Tissue proteins were extracted with RIPA buffer (Santa Cruz, Dallas, Texas, USA) with protease inhibitor cocktail (Roche Diagnostics, Meylan, France). Clear lysates were prepared by centrifugation at 10000g for 10 min, and protein concentrations were assessed using the QuantiPro BCA assay kit (Sigma-Aldrich).
Equal protein amounts of each extract were separated in 12.5% SDS-polyacrylamide gel and transferred onto 0.45 mm nitrocellulose membranes (Whatman). Membranes were blocked with 5% dry milk in 0.1% tween in PBS (PBST) for 45 min at RT, and then incubated overnight at 4 C with either mouse anti-claudin 4 antibody (Life Technologies, Saint-Aubin, France; 1/500) or anti-GAPDH antibody used as internal standard. After washing in PBSTemilk, membranes were incubated for 1 h at RT with horseradish peroxidase-conjugated secondary antibody (Amersham ECL Kit; 1/5000) and washed. Bands were identified using Luinata Forte substrate (Merc Millipore, Darmstadt, Germany). Relative values of the band density were estimated using ImageJ software (NIH, Bethesda, MD, USA) and claudin 4 expression was assessed relative to GAPDH for each sample analyzed.
Histological and lesion analyzes
Animals were sacrificed and immediately after, the irradiated area which corresponds to a white, non-vascularized zone was measured (photos were taken with Zeiss binocular (x 0.6)). Then, the colon was collected and fixed in 4% formaldehyde and embedded in paraffin. Paraffin embedded colons were cut on a rotary microtome (Leica Microsystems AG, Wetzlar, Germany) into serial circular sections of 5 mm, spaced 150 mm (all damaged zone) and stained with hematoxylin-eosin-saffron (HES). The severity of colorectal damage induced by irradiation was assessed using an injury score. Determination of the injury score was based on mucosal damages (ulceration, epithelial atypia, and regenerative crypts), edema, colitis cystica profunda, vascular sclerosis and muscular dystrophy. Graduation of the injury was 0 ¼ null; 10 ¼ slight; 20 ¼ moderate and 30 ¼ severe.
Immunohistochemistry
For immunohistochemistry (IHC), sections were deparaffinized and hydrated. Serial slides were used for GFP, PCNA and CD68 staining. Tissue sections were treated with 0.1% triton X-100 (Sigma-Aldrich) in PBS 1x (Life Technologies) at room temperature (RT) for 10 min. Then endogenous peroxidases were inhibited by incubation with 3% H 2 O 2 in methanol at RT for 10 min. For GFP (Green Fluorescent Protein) IHC, after saturation (X0909, DakoCytomation, Courtaboeuf, France), goat anti-GFP diluted to 1/1000 (ab6673, Abcam, Cambridge, UK) was applied for 1 h at 37 C. Sections were incubated with impress reagent kit anti-goat Ig (MP7405, Vector) for 20 min at RT. For CD68 IHC, enzymatic retrieval solution (Proteinase K, S3020, DakoCytomation) was performed. After saturation, mouse anti rat CD68 (MCA341R, AbDserotec, Oxford, UK) at 1 mg/mL was applied for 1 h at 37 C. Sections were incubated with Envision kit anti-mouse HRP (K4002, DakoCytomation) for 30 min at RT. For PCNA (Proliferating Cell Nuclear Antigen) immunostaining, tissue sections were placed in an antigen retrieval solution (0.01 M citrate buffer, pH ¼ 6 (DakoCytomation) for 15 min at 350 W) and quenched for endogenous peroxidases as described above. After saturation, mouse anti PCNA (M0879, DakoCytomation) at 525 mg/ml was applied for 1 h at 37 C. Sections were incubated with Envision kit anti-mouse HRP for 30 min at RT.
Staining was developed with Histogreen substrate (E109, Eurobio, Les Ulis, France). Then, sections were counterstained with nuclear fast red (H3403, VectorLabs, Burlingame, CA, USA), dehydrated and mounted. Isotype control antibodies are used as negative controls.
Double staining of GFP and TUNEL
In order to identify if Ad-MSC expressing GFP are apoptotic, double staining of GFP and terminal deoxynucleotidyl transferasemediated dUTP nick end labeling (TUNEL) was performed. Following immunohistochemical staining of GFP, as described above (using donkey anti-goat Alexa as secondary antibody), the TUNEL was performed using the In Situ Cell Death Detection Kit (Roche Diagnostics).
Secretome analysis
Proteins released from Ad-MSCs during culture in 2D and 3D were quantified following 7 days of culture. On day 6, culture media was aspirated and cells washed using PBS. Medium without serum was added to the cells and then incubated for 24 h. Media was then evaluated for secretome products using commercial rat ELISA kits. Data normalization for the secreted factors required DNA quantification using Picrogreen dsDNA quantification kit (Invitrogen).
Statistical analysis
All data are presented as mean ± SEM. Statistical analyzes were performed using Graph Pad Prism 5.0 (GraphPad, San Diego, CA). Statistical significance was determined using one-way ANOVA followed by Tukey's post-test for multiple groups, or two-way ANOVA followed by Bonferroni's post-test for multiple groups with different variables, or t-test when changes were compared between two groups. Statistical significance was set at p < 0.05.
Results
Formulation and characterization of Si-HPMC for colonoscopy procedure
Local treatment for colorectal side effects of radiotherapy can be administered using the operative channel of a colonoscope. Our aim was to determine the appropriate Si-HPMC concentration that provides the best compromise between the injectability within the specific catheter system and optimized cell protection. Si-HPMC viscosity was measured using a rheometer under a variable shear stress. Two Si-HPMCs at final concentrations of 1% and 1.5% (w/v) were tested before cross-linking, and measurements showed an increase in viscosity with Si-HPMC concentration ( Table 1) . The results showed that, in these conditions, the peak force applied was 1.34 kg for 1% Si-HPMC and 3.52 kg for 1.5% Si-HPMC concentrations (Table 1) . These results therefore determined that both Si-HPMC concentrations could be injected through the colonoscope Table 1 Formulation and characterization of Si-HPMC for colonoscopy procedure. Viscosity, injectability, gel-point and elastic modulus of Si-HPMC at 1% and 1.5%. N ¼ 3. catheter. Table 1 shows that with respect to temperature, the gelpoint significantly decreased at body temperature (37 C) compared to room temperature (21 C) at both Si-HPMC concentrations (p < 0.05). A reduction in the Si-HPMC concentration resulted in an increase in the gel-point, whereby a positive correlation between Si-HPMC concentration and gelation time was found at both temperatures measured (p < 0.05). Moreover, a significant difference between Si-HPMC concentrations was found in terms of elastic modulus (G') with a lower value for 1% Si-HPMC compared to 1.5%, when no difference was observed between room and body temperature. However, both values are compatible with soft tissue (i.e. colon) application. Taken together, these analyses determined that 1% and 1.5% Si-HPMC hydrogel have the required properties: Si-HPMC viscosity enables it to be injected at 1% and 1.5% with the colonoscope. Its reticulation kinetic at room temperature is compatible with manipulation by the surgeons in the operating theatre. Moreover, once injected in vivo (37 C), the mechanical properties of the Si-HPMC were not modified and the reticulation time is fast (12e19 min) ensuring optimal cell protection.
Viability, morphology and secretome analyses of Ad-MSCs embedded in Si-HPMC
The viability of Ad-MSCs in 1% and 1.5% hydrogel has been tested in vitro for 21 days. When Ad-MSCs were mixed in 1% Si-HPMC, we observed that not all the cells were entrapped and some cells remained attached to the bottom of the culture plate (data not shown). Cells mixed with a 1.5% Si-HPMC concentration appeared to be fully entrapped within the hydrogel, thus viability and cytokine release were only assessed for this condition. We quantified that 95% of cells were viable after 21 days of culture (Fig. 1A) . Morphology of Ad-MSCs embedded in Si-HPMC has been assessed: we observed that cells in 3D have a spherical morphology which is not modified with the stiffness of the hydrogel (Fig. 1B) . We observed, in the viability experiments, that the number of cells is not modified with time. To verify the lack of proliferation in the hydrogel, we used PCNA (Proliferating Cell Nuclear Antigen) immunostaining, and confirmed that Ad-MSCs in Si-HPMC do not proliferate whatever the stiffness of the hydrogel (Fig. 1C) . Since it has been established that the therapeutic benefit of MSC-based therapy is associated with their capacity to secrete a broad range of bioactive molecules, we tested the ability of Ad-MSCs embedded in 1.5% Si-HPMC (3D) to secrete growth factors involved in epithelial regeneration (IGF1-2, KGF, IL11, EGF and FGF2), proangiogenesis (VEGF) and anti-inflammatory processes (PGE2 and IL10), compared with Ad-MSCs cultivated in a monolayer (2D). To normalize the quantity of secreted molecules according to cell number, all the results were expressed according with DNA content. We demonstrated that Ad-MSCs mixed in the hydrogel kept their ability to secrete molecules (Fig. 1D) . Interestingly, Ad-MSCs embedded in 1.5% Si-HPMC were able to secrete higher concentrations of IGF-1 and PGE2 compared to Ad-MSCs in 2D.
The therapeutic benefit of Si-HPMC-assisted cell therapy on colonic epithelial structure
To determine the Ad-MSC treatment procedure that produces the greatest therapeutic benefit, we initiated in vivo experiments using the procedure described in section 2.8 (supplementary figure) and the histological structure of the colon was initially assessed. To analyze the improvement in the colonic structure, two quantifications were performed. In the first, we quantified the severity of the lesion (lesional score Fig. 2A and B) and in the second we measured the extent of the damage (Fig. 2C) . Histological sections of normal colon showed organized crypts. In the irradiated field, three zones were differentiated according to epithelial parameters: the ulcerated, atypical and regenerative areas (Fig. 2A) . The therapeutic effect of the treatments on epithelial injury was assessed in the various zones separately. In the regenerative and atypical zones, we noted that 5 Â 10 6 of IV-injected Ad-MSCs and 1 Â 10 6 of locally-injected Ad-MSCs in 1.5% hydrogel induced a significant reduction in the epithelial injury score one week after treatment (p < 0.05) (Fig. 2B) . Quantification of the number of ulcerated, atypical and regenerative slides was performed. We observed that the number of ulcerated slides was decreased (p ¼ 0.034) in rats treated with 1.5% Ad-MSC þ Si-HPMC compared with irradiated animals. Moreover, this latter treatment significantly increased the number of regenerative slides in comparison with irradiated animals (p < 0.05) (Fig. 2C) . Overall, these results demonstrate that locally-injected Ad-MSCs embedded within 1.5% Si-HPMC induce a significant reduction in radiation-induced colonic epithelial damage as compared to Ad-MSCs injected intravenously or locally alone. These data also suggest that Ad-MSCs embedded in 1.5% Si-HPMC increase the regenerative process in the margins of the lesion leading to a reduction in the ulcerated area.
The therapeutic benefit of Si-HPMC-assisted cell therapy on epithelial barrier function
Intestinal permeability is one of the primordial functions of the gut epithelium and is commonly used as a marker of epithelial integrity. The colonic epithelium forms a selective barrier which prevents the penetration of luminal content (Fig. 3A) . Epithelial barrier function was assessed in our experimental rat model, using the system of Ussing Chambers measuring colonic permeability to FD4 and intact HRP. Colonic irradiation induced an increase in colonic permeability to FD4 compared with control rats, (0.51673 cm/s vs. 0.926619 cm/s respectively) (Fig. 3B) . Intravenous injection of Ad-MSCs did not modify colonic hyperpermeability to FD4 induced after irradiation. Locally-injected Ad-MSCs combined with 1.5% Si-HPMC significantly decreased colonic hyperpermeability to FD4 induced after irradiation (Fig. 3B) . Colonic irradiation also induced a significant increase in colonic permeability to intact HRP in comparison with controls (Fig. 3C, p < 0.05) . A significant effect on epithelial hyperpermeability to intact HRP was observed in rats treated with Ad-MSCs embedded within hydrogel at both concentrations (Fig. 3C) . However, Ad-MSCs injected intravenously did not restore significantly HRP permeability to control level. It should be noted, however, that neither 1% nor 1.5% Si-HPMC injected alone had a beneficial effect on radiation-induced hyperpermeability to FD4 or HRP (Fig. 3B and C) .
The colonic epithelial barrier is maintained by intercellular junctional complexes, such as Tight-Junctions (TJs) (Fig. 3A) . TJs are composed of transmembrane proteins including claudin-4 amongst others. Western blotting experiments demonstrated a decrease in claudin-4 expression after colorectal irradiation compared with non-irradiated rats. In accordance with FD4 permeability measurement, Ad-MSCs injected intravenously had no effect whereas local treatment with Ad-MSCþ 1.5% Si-HPMC reversed the effect of irradiation on claudin-4 expression (Fig. 3D) .
Potentiation of Ad-MSC engraftment in the colonic mucosa by 1.5% Si-HPMC
To localize Ad-MSCs in the host tissue, cells were prepared from the adipose tissue of GFP-transgenic SD rats before IV or local injection into irradiated SD rats. We then analyzed Ad-MSC engraftment on colonic sections taken every 150 mm throughout the distal colon. A previous study had revealed the presence of some GFP cells in the mesentery near the vessels and in the submucosa, one week after irradiation and IV injection of MSCs [4] . Here, the number of slides with Ad-MSC GFP-positive cells was counted in each of the treated groups. In this study, Ad-MSCs were injected into established damage (3 weeks) and no GFP-positive cells could be detected in the irradiated colonic mucosa after IV treatment (data not shown). However, GFP-positive slides were observed after AdMSCs were injected locally with the colonoscope and greater numbers of GFP-positive slides were detected in rats treated with Ad-MSCþ 1.5% Si-HPMC ( Fig. 4A and B) . Moreover, when GFPpositive cells were detected on a slide, a greater amount of GFP cells was observed in the colon of rats locally injected with AdMSCs embedded in 1.5% Si-HPMC compared with rats locally injected with cells alone (Fig. 4B, right graph) . We observed that one week after in vivo injection of Ad-MSCs embedded in 1.5% Si-HPMC into chronic colonic damage, most of the cells were localized at the periphery of the hydrogel and had a fibroblastic-like shape. After later time points (14 and 21 days after injection), Ad-MSC GFP-positive cells were still observed only in the group Ad-MSC þ hydrogel. Lower quantity of cells was observed and they were fully protected by the hydrogel (Fig. 4C ).
Fate of Ad-MSCs engrafted in irradiated colonic tissue
To analyze the behavior of locally injected Ad-MSCs in irradiated tissue, we tested their proliferative capacity and whether detected cells were apoptotic. Colorectal irradiation leads to a hostile microenvironment with high oxidative stress, ischemia and inflammation which could limit the viability of the injected cells. The proliferation of Ad-MSCs in irradiated colonic tissue was assessed using PCNA staining. One week after the injection, we observed that the majority of the cells were not proliferating independently in the presence of the hydrogel (Fig. 5A) . TUNEL staining was used to detect the cells that underwent programmed cell death. In our experiments, we demonstrated that Ad-MSCs, whether embedded or not in hydrogel, are not apoptotic (Fig. 5B ) (Data not shown for PCNA and TUNEL staining without hydrogel).
Si-HPMC-embedded Ad-MSC attenuates macrophage infiltrate
Macrophage infiltrate is persistent in late radiation colonic damage. Macrophages are involved in tissue clearing and initiate tissue remodeling after tissue injury, but they also play a role in perpetuating inflammation. In this study, we investigated macrophage infiltrate using CD68 antigen immunostaining (Fig. 6) . We demonstrated that one week after injection of 1.5% Si-HPMC alone in the irradiated mucosa, few CD68-positive cells were detected. A greater amount of macrophages was detected near Ad-MSCimplanted cells compared with Ad-MSCs embedded in Si-HPMC ( Fig. 6A and B) .
To understand the mechanism of action by which Ad-MSCs þ Si-HPMC could decrease macrophage infiltrate, we questioned whether the secretion of chemoattractant molecules by Ad-MSCs is modified by their embedding in 1.5% Si-HPMC. Moreover, chronic side effects induced after irradiation are associated with IL1b and TGFb cytokine secretion. Therefore, we also tested the secretion capacities of Ad-MSCs after these pro-inflammatory stimulations retracing the in vivo situation. Using an ELISA assay, we demonstrated that in the absence of stimulation, embedding cells in hydrogel did not modify the chemoattractant secretion profiles (Fig. 7A) . However, when Ad-MSCs were stimulated with IL-1b and TGF-b, as in an in vivo situation, it was shown that Ad-MSCs secreted fewer chemoattractant molecules in 3D than in 2D (Fig. 7A) . Numerous studies demonstrated that Ad-MSCs secrete anti-inflammatory molecules as well as high quantity of VEGF molecule involved in pro-angiogenesis process. In this study, we analyzed the modifications of these molecules following hydrogel- embedding and stimulations (Fig. 7B) . We determined that PGE2 secretion is increased in 3D conditions, however IL10 is not modified after hydrogel embedding and Il1b þ TGFb stimulations. We also demonstrated that stimulated Ad-MSCs secrete more VEGF in 3D compared with 2D configuration (Fig. 7B ).
Discussion
Intravenous injection of MSCs has been shown to improve the intestinal regeneration process after irradiation [3, 4, 9, 29] . The reparative potential of MSCs has been shown to be mediated by the release of a broad spectrum of soluble factors [8] . Systemic infusion of MSCs has been promulgated as a simple, reproducible and safe delivery strategy for use in clinics [7, 18] . The ability of MSCs to host injured tissues may result in localized therapeutic benefits. However, the potential of MSC migration to the injured organs after intravenous (IV) injection is impeded by cell trapping within the lung [14] . Moreover, the optimal time-point for IV MSC delivery is unknown and is dependent upon the secretion of chemoattractant molecules like SDF1a [30] . In view of the uncertain fate of IVinjected cells, local injection of MSCs, implanted directly into the lesion site, which has been tested in different tissues [31, 32] , allows fewer cells to be injected and provides a greater therapeutic benefit [31] . For the first time, this study proposes and demonstrates the feasibility of colonoscopy to deliver MSCs directly into the colon without surgery, using imaging and syringe catheter systems. However, once injected into the injured tissue the cell survival rate could be limited due to the ischemic and inflammatory microenvironment induced after irradiation. Growing evidence suggests that synthetic biomaterials are an encouraging approach to sustaining the long-term cell viability of stem cells in situ, by creating an optimal niche that preserves the cells. These scaffolds offer the potential to appropriately deliver cells into the injured site, optimizing the therapeutic effect of stem cell therapy. Amongst the biomaterials used in regenerative medicine, hydrogels are likely the most suitable materials since they display injectability and crosslinking properties. We used a Si-HPMC hydrogel that displays rheological properties appropriate to its implantation via miniinvasive surgery [26] . The advantage of this hydrogel is its selfsetting property without any addition of cross-linking toxic agents. It is a hydrophilic and neutral hydrogel with no bioactivity. Its influence is to provide a protective barrier and to maintain the cell in a non-adherent shape. It has already been demonstrated that intra-myocardial delivery of MSC-embedded Si-HPMC preserves cardiac function after myocardial infarction [22] . Intra-colonic injection of Ad-MSCs has not yet been proposed as a pre-clinical treatment for radiation-induced colorectal damage. In this study, we established Si-HPMC with rheological properties that can be loaded through the syringe catheter system of a colonoscope. The gelation time of Si-HPMC has been determined to enable a cellhydrogel mixture as well as its injection in vivo. This time is suitable for manipulation in an operating theatre and could be used by surgeons. Furthermore, we demonstrated that Ad-MSCs in Si-HPMC are 95% viable for up to 21 days in vitro and are biologically active. Indeed, we determined that Ad-MSCs in 3D configuration in 1.5% Si-HPMC displayed a round shape in vitro that has no influence on their ability to secrete molecules involved in epithelial regeneration, angiogenesis or the anti-inflammatory process.
MSCs from bone marrow have been used to treat radiationinduced proctitis in patients over-irradiated at Epinal hospital. It has been demonstrated that MSCs reduced pain and the number of episodes of diarrhea in three patients who were resistant to symptomatic treatments [6] . The aim of this study was to find a novel clinically-applicable procedure for MSC treatment of colorectal damage that improves the therapeutic benefit whilst at the same time decreasing the number of injected cells. We used a rat model of gastrointestinal complications following radiotherapy. Patients treated for rectal adenocarcinoma with preoperative radiotherapy receive a total dose of 45Gy, delivered in fraction of 1.8 or 2Gy. However, previous works performed in rats showed no changes on colonic structure after fractionated irradiation [33] . Here, the irradiation methodology used is a single dose of 29 Gy which induces severe colorectal damage similar to that observed in patients subjected to radiotherapy [4] . We analyzed the structure and intestinal permeability which is one of the primordial functions of the gut epithelium and is commonly used as a marker of epithelial integrity. Increased intestinal permeability has already been demonstrated in rat ileum after 5Gy abdominal irradiation [34, 35] . This result has been confirmed in patients affected by breast cancer, sarcoma and colorectal cancer treated with different chemotherapy agents or after radiotherapy [36e40] . In our rat model of severe and chronic radiation-induced damage [3] , we demonstrated an alteration of the colonic histological structure associated with an increase in epithelial permeability of colon/ rectum segments to FD4 and HRP macromolecules 4 weeks after irradiation. These data are of particular importance, and demonstrate the clinical relevance of our animal model, since the colon delivers a plentiful source of luminal antigens within the range of molecular weights herein assessed, which may generate mucosal injury and be a reservoir of systemic infections [41] .
This study confirmed previous results demonstrating the therapeutic benefit of 5 million IV-injected Ad-MSCs on epithelial structure after localized irradiation [5] . A decrease in the number of cells (1 million), whether IV-or locally-injected, has no therapeutic effect. We also observed that Ad-MSCs embedded in 1% Si-HPMC produced no improvement in epithelial structure. This result can be explained by our in-vitro observations demonstrating that the rheological properties of 1% Si-HPMC do not allow entrapment of all the cells since some cells remain attached to the culture dish and are not inside the hydrogel. However, Ad-MSCs embedded in 1.5% Si-HPMC statistically improved all the parameters tested in this study. This therapeutic benefit is associated with an increase in Ad-MSC engraftment in the colonic mucosa compared to all other groups. Different therapeutic effects have been proposed for MSCs, but it is now well established that the paracrine effect is the most prevalent rather than differentiation or transdifferentiation in epithelial cells [42, 43] . They have been shown to act therapeutically by releasing pro-regenerative factors and/or by modulating the immune response through several factors [44] . Thus, increasing Ad-MSC engraftment could help improve their therapeutic benefit. Moreover, we determined that 7 days after in vivo injection in the irradiated colonic mucosa, Ad-MSCs embedded in 1.5% hydrogel were not apoptotic. It could be hypothesized that 1.5% Si-HPMC preserves the cells at various levels. It has been reported that the cells are protected from mechanical forces, by the hydrogel, during syringe needle flow [45] . This result suggests that cells could be protected by Si-HPMC in the early stages of the treatment process. Moreover, when Ad-MSCs were recovered after culture expansion, then injected in saline solution into the tissue, their lack of adhesion to extracellular matrix can promote apoptotic signaling. 1.5% Si-HPMC could therefore be an appropriate scaffold to maintain cell viability within the tissue and derive a therapeutic benefit. Indeed, strategies using genetically-modified MSCs to decrease their apoptosis have been successfully applied in animal models [46, 47] . These interesting experiments shed light on the correlation between the therapeutic benefit and the inhibition of MSC apoptosis. However, their use in clinics cannot be applied at present. Another hypothesis is that 1.5% Si-HPMC could protect the cells from the inflammatory environment induced after irradiation. It has been demonstrated that irradiation induces chronic secretion of proinflammatory molecules as IL1b and TGFb [19, 48] and reactive oxygen species [49] . However, it has been observed that molecules are able to diffuse through the scaffold. Therefore under these conditions, we observed a statistical increase in VEGF secretion in 3D after stimulation with IL1b and TGFb. It is therefore likely that Ad-MSCs in 1.5% Si-HPMC are able to resist the inflammatory environment. Indeed, MSCs have been shown to resist irradiation due to their high antioxidant capacities [50] . Moreover, it is now acknowledged that the inflammatory environment to which MSCs are exposed plays a pivotal role in activating their immunosuppressive functions [51] . As macrophage infiltrate is persistent in late radiation colonic damage [19, 20] , our analyses focused on this type of innate immune cells. We observed that high infiltration of macrophages was seen in the vicinity of Ad-MSCs that were not embedded within the hydrogel. Interestingly, there were fewer CD68 þ macrophages near Ad-MSCs embedded in 1.5% Si-HPMC.
This observation led us to hypothesize that Ad-MSCs were recognized by host macrophages in a non-consanguinous situation. This fact has also been observed in another study [52] and various hypotheses could be made. It has been argued that the culture expansion modified membrane protein expression of MSCs, particularly with modification of HLA membrane expression, potentially inducing recognition by macrophages [53, 54] . Another explanation is the initialization of tissue clearing by macrophages in the presence of a huge amount of exogenous cells in the tissue structure. Indeed, it has been demonstrated that autologous MSCs injected in immune-deficient mice lacking T, B and NK cells have a short survival time [15] , indicating that other cell types, like macrophages, could contribute to the clearance of MSCs. Interestingly, our results demonstrated limited macrophage infiltrate near the hydrogel-embedded Ad-MSCs. This result is of particular importance since 1.5% Si-HPMC seems to protect Ad-MSCs from the macrophages. In the context of a clinical application, it will be interesting to test whether the same result is observed with AdMSCs from other strains embedded in Si-HPMC.
To understand the molecular mechanism of macrophage infiltration modulation, we analyzed the secretion of chemoattractant molecules by Ad-MSCs, in a native context or stimulated by IL1b and TGFb which are secreted in colonic mucosa after irradiation. We observed that the secretion of IL-8 and MCP-1 in particular, is higher in non-entrapped cells than in Ad-MSCs in 3D after stimulation with IL1b and TGFb. These results suggest a modification of the phenotype of Si-HPMC-embedded MSC compared to cells in culture plastic flask. Various studies already demonstrated a modification of secretion abilities when the cells are in 3D compared with cells cultured in monolayer [21, 55, 56] . Moreover, it has also been suggested that 3D culture conditions are closest of the in vivo environment compared with the simplicity of 2D culture that seems a reductionist approaches to understand the physiological behavior of cells [57] . Besides, a recent study demonstrated that topographical cues influence the soluble factors secreted by MSCs and modify the communication between MSCs and macrophages [56] . Similarly, Swartzlander et al. have demonstrated that MSCs embedded in synthetic hydrogel were able to attenuate macrophage activation [58] . These findings are of great importance and suggest that MSCs may be able to combat foreign body response (FBR) via macrophage cross-talk, the primary orchestrators of FBR [59] . Altogether, these data could explain our in vivo observations, highlighting a decrease in CD68 þ macrophages near the hydrogel embedded with Ad-MSCs compared with AdMSCs alone. Our results suggest that the hydrogel exerts an immunoprotective function through two mechanisms: a decrease in macrophage chemoattractant secretion by embedded cells in a pro-inflammatory context and a delay in the tissue clearance of AdMSCs trapped in the hydrogel.
In conclusion, we developed a Si-HPMC with rheological properties compatible with injection through a colonoscope catheter. The defined properties are compatible with use by surgeons in an operating theatre. We demonstrated that Ad-MSCs embedded in 1.5% Si-HPMC are biologically active in normal conditions and are also able to modulate their secretome according to the inflammatory context. Using a clinically-relevant animal model, we determined that local injection of 1 million Ad-MSCs embedded in 1.5% Si-HPMC hydrogel improves the structure of colonic mucosa damaged after irradiation. Ad-MSCs injected according to this protocol have a greater therapeutic benefit on colonic function measured by epithelial permeability compared with the intravenous injection of Ad-MSCs which is the protocol currently used in clinics. This therapeutic benefit is associated with increased engraftment of viable Ad-MSCs in the colonic submucosa. This study also shows, for the first time, that Ad-MSCs embedded in 1.5% Si-HPMC are able to reduce macrophage infiltration in vivo near the injection point. This innovative procedure produces encouraging results and may represent a breakthrough in the use of stem cellassisted biomaterial therapy. This approach will allow a miniinvasive intervention and could be proposed to patients suffering from late radiotherapy side effects.
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